Suppr超能文献

微小RNA-138靶向SP1以抑制肝癌细胞的增殖、迁移和侵袭。

MicroRNA-138 targets SP1 to inhibit the proliferation, migration and invasion of hepatocellular carcinoma cells.

作者信息

Liu Chongzhong, Zhu Jiankang, Liu Fengyue, Wang Yadong, Zhu Min

机构信息

Department of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China.

出版信息

Oncol Lett. 2018 Jan;15(1):1279-1286. doi: 10.3892/ol.2017.7357. Epub 2017 Nov 8.

Abstract

The identification of microRNAs (miRNAs/miRs) has enabled the improved understanding of the carcinogenesis and progression of hepatocellular carcinoma (HCC). miRNAs are small non-coding RNAs comprised of 19-24 nucleotides that regulate the expression of target genes. In the present study, miR-138 was demonstrated to be downregulated in human HCC tissues and cell lines. Restoration of miR-138 expression repressed the proliferation, migration and invasion of HCC cells. Furthermore, specificity protein 1 (SP1) was identified as a target gene of miR-138 in HCC using bioinformatics analysis, luciferase reporter assay, reverse transcription-quantitative polymerase chain reaction and western blot analysis. Knockdown of SP1 produced similar suppressive effects to those induced by miR-138 overexpression in HCC cells. These results indicate that miR-138 targeted SP1 to repress the growth, migration and invasion of HCC cells, and may therefore represent a therapeutic target in human HCC.

摘要

微小RNA(miRNA/miR)的鉴定有助于加深对肝细胞癌(HCC)发生发展的理解。miRNA是由19-24个核苷酸组成的小型非编码RNA,可调节靶基因的表达。在本研究中,miR-138在人类HCC组织和细胞系中被证明表达下调。恢复miR-138的表达可抑制HCC细胞的增殖、迁移和侵袭。此外,通过生物信息学分析、荧光素酶报告基因检测、逆转录-定量聚合酶链反应和蛋白质印迹分析,特异性蛋白1(SP1)被确定为HCC中miR-138的靶基因。敲低SP1在HCC细胞中产生了与miR-138过表达诱导的类似抑制作用。这些结果表明,miR-138靶向SP1以抑制HCC细胞的生长、迁移和侵袭,因此可能是人类HCC的一个治疗靶点。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验